Follow
Alzinova AB
Nasdaq First North GM (Sweden)
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
ALZ
SE0007413455
Nasdaq First North GM
Sweden (SE)
Details of share in Alzinova AB with ticker ALZ
Status
Active
Order book id
413E
Amount of instruments
7 633 415
Par value
0.2630
Market cap
Currency
SEK
Segment
First North
First trading date
25 Nov 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
9.40 SEK
23.8M SEK
08 Oct - 22 Oct 2015
IPO in Alzinova AB
Type
Price
Pre-money valuation
Time
Files
Exercise
12.20 SEK
52.6M SEK
04 Nov - 25 Nov 2016
Option exercise terms for ALZ TO 1
Type
Price
Pre-money valuation
Time
Files
Targeted issue
22.00 SEK
24 Oct - 09 Nov 2018
Share issue in Alzinova AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
22.00 SEK
120.5M SEK
21 Nov - 05 Dec 2018
Share issue in Alzinova AB
Type
Price
Pre-money valuation
Time
Files
Market move
26.80 SEK
201.8M SEK
11 Mar 2019
Listing of Alzinova AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Rights issue
6.50 SEK
49.62M SEK
30 Sep - 14 Oct 2020
Share issue in Alzinova AB
Type
Ticker
ISIN
Market
OPTION
ALZ TO 2
SE0014957270
Nasdaq First North GM
Sweden (SE)
Details of option in Alzinova AB with ticker ALZ TO 2
Status
Inactive
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share in the Company for price corresponding to seventy (70) percent of the volume-weighted average price paid for the Company's share on Nasdaq First North Growth Market for a period of ten (10) trading days immediately preceding January 19, 2022, however not less than SEK 6.5 and not more than SEK 11 per share. Subscription period for the warrants is valid from January 24, 2022 until February 07, 2022.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.50-11.00 SEK
24 Jan - 07 Feb 2022
Option exercise terms for ALZ TO 2
Type
Ticker
ISIN
Market
SHARE
ALZ
SE0007413455
Nasdaq First North GM
Sweden (SE)
Details of share in Alzinova AB with ticker ALZ
Status
Active
Order book id
413E
Amount of instruments
7 633 415
Par value
0.2630
Market cap
Currency
SEK
Segment
First North
First trading date
25 Nov 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
9.40 SEK
23.8M SEK
08 Oct - 22 Oct 2015
IPO in Alzinova AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
22.00 SEK
24 Oct - 09 Nov 2018
Share issue in Alzinova AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
22.00 SEK
120.5M SEK
21 Nov - 05 Dec 2018
Share issue in Alzinova AB
Type
Price
Pre-money valuation
Time
Files
Market move
26.80 SEK
201.8M SEK
11 Mar 2019
Listing of Alzinova AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Rights issue
6.50 SEK
49.62M SEK
30 Sep - 14 Oct 2020
Share issue in Alzinova AB
Type
Ticker
ISIN
Market
OPTION
ALZ TO 1
SE0007465208
Nasdaq First North GM
Sweden (SE)
Details of option in Alzinova AB with ticker ALZ TO 1
Status
Archived
Order book id
115944
Amount of instruments
1 186 000
Market cap
Currency
SEK
Trading period
25 Nov 2015 - 23 Nov 2016
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company.
Update (04.11.2016): The exercise period of warrants of series TO1 begins today.
Update (18.11.2016): Reminder of the exercise of warrants of series TO 1.
Type
Price
Pre-money valuation
Time
Files
Exercise
12.20 SEK
52.6M SEK
04 Nov - 25 Nov 2016
Option exercise terms for ALZ TO 1
Type
Ticker
ISIN
Market
OPTION
ALZ TO 2
SE0014957270
Nasdaq First North GM
Sweden (SE)
Details of option in Alzinova AB with ticker ALZ TO 2
Status
Inactive
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share in the Company for price corresponding to seventy (70) percent of the volume-weighted average price paid for the Company's share on Nasdaq First North Growth Market for a period of ten (10) trading days immediately preceding January 19, 2022, however not less than SEK 6.5 and not more than SEK 11 per share. Subscription period for the warrants is valid from January 24, 2022 until February 07, 2022.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.50-11.00 SEK
24 Jan - 07 Feb 2022
Option exercise terms for ALZ TO 2
People
Number of Employees
2 people
Per Wester
CEO
Björn Larsson
Chairman of the board
Jan Holmgren
Board member
Björn Larsson
Board member
Clas Malmeström
Board member
Björn Löwenadler
Board member
Anders Waas
Board member
Carol Routledge
Board member
Company Details
Sector
HEALTH CARE

Address
Erik Dahlbergsgatan 11A
Zip code
411 26
City/district
Göteborg
Country
Sweden (SE)
Registration number
556861-8168
LEI code
549300K3IMVT20EK2S13
First trade date
25 Nov 2015
Registration date
19 Aug 2011
Short name
Alzinova

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date